All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

Source: [NPR News](https://www.npr.org/2026/06/18/nx-s1-5863570/flu-vaccine-mrna-moderna-fda)

Sponsored